Clinical operations leaders are not prepared for the downstream impact of GPT-Rosalind. Explore the hidden trial infrastructure risks of...
Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...
QMENTA vs. Flywheel.io: Compare FDA-cleared CNS clinical AI vs. enterprise R&D infrastructure. See which medical imaging platform fits your trial.
QMENTA vs Medidata Rave Imaging: compare AI biomarkers, central review, imaging EDC, and which platform fits your clinical trial.
5 warning signs your imaging core facility has outgrown its data infrastructure — from data detective syndrome to compliance gaps — and how modern...
Learn how to integrate AI tools into medical imaging workflows using QMENTA’s cloud platform, including benefits, challenges, and a 3-step SDK...
IBM Watson pioneer Dr. John E. Kelly III shares his perspective on AI adoption barriers, data quality, and the future of AI-enabled neurological...
Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis